default author photo

Marie-Anne Rameix-Welti

Université Paris Saclay

SCHOLARLY PAPERS

4

DOWNLOADS

744

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Real-World Emergence of Nirsevimab Resistance in RSV-B Breakthrough Infections

Number of pages: 25 Posted: 08 Sep 2025
Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris Saclay, Université Paris Cité - Institut Pasteur, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris-Saclay - Institut Pasteur, Paris-Est University - Inserm U955, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, Université de Toulouse - CHU de Toulouse, University of Nantes - CHU Nantes, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Hôpital Necker-Enfants Malades, University of Montpellier - Virulence bactérienne et infections chroniques (VBIC), CHU Poitiers, University of Bordeaux, Hôpital Paul-Brousse - Service de Virologie, Sorbonne University, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, CHU de Rennes - Department of Virology, CHRU Tours, University of Strasbourg - Federation of Translational Medicine of Strasbourg (FMTS), University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), University of Lille - CHU Lille, CHU Caen, Centre Hospitalier Victor Dupouy, University of Paris-Saclay - Laboratoire de Microbiologie, University of Lorraine - CNRS, LCPME, F-54000, Université Paris Nord - Laboratoire de Microbiologie Clinique, CHU Rouen, Université d’Orléans, University of Angers - CHU Angers, CHU Montpellier, Amiens Picardie University Hospital - Department of Virology, Université Clermont Auvergne - CHU Clermont-Ferrand, Université Paris 7, Hôpital Saint Louis - Service de Virologie, Université Paris Cité, CHU La Réunion - Hôpital F Guyon, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University Hospital of Henri-Mondor, APHP - Department of Microbiology, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, CHU de la Martinique, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, University of Paris-Saclay - Institut Pasteur, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, University of Paris-Saclay - Institut Pasteur, Université Paris Est Créteil (UPEC) - IMRB, Université Paris Saclay and Independent
Downloads 302 (250,461)

Abstract:

Loading...

RSV, immunoprphylaxis, nirsevimab, resistance

2.

Genotypic and Phenotypic Characterisation of Rsv after Nirsevimab Breakthrough Infections in a Large Multicentre Observational Real-World Study

Number of pages: 30 Posted: 16 Jul 2024
Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris Saclay, Université Paris Cité - Institut Pasteur, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris-Saclay - Institut Pasteur, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Université de Toulouse - CHU de Toulouse, CHU Caen, University of Paris-Saclay - Laboratoire de Microbiologie, Université Paris 7, Hôpital Saint Louis - Service de Virologie, University of Nantes - CHU Nantes, Université Clermont Auvergne - CHU Clermont-Ferrand, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), CHU Rouen, Sorbonne University - Laboratoire de virologie, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, Hôpital Necker-Enfants Malades, CHU Montpellier, CHRU Tours, Centre Hospitalier Victor Dupouy, CHRU Brest - Morvan, Université Paris Nord - Laboratoire de Microbiologie Clinique, Université d’Orléans, University of Bordeaux - CHU de Bordeaux, University of Angers - CHU Angers, CHU de Rennes - Department of Virology, CHU Poitiers, Université Paris Cité, Hôpital Paul-Brousse - Service de Virologie, Amiens Picardie University Hospital - Department of Virology, University of Lille - CHU Lille, University of Lorraine - CNRS, LCPME, F-54000, University of Limoges - CHU Limoges, University of Strasbourg - Federation of Translational Medicine of Strasbourg (FMTS), Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University Hospital of Henri-Mondor, APHP - Department of Microbiology, CHU de la Martinique, University of Paris-Saclay - Institut Pasteur, Université Paris Cité, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, Université Paris Cité - Institut Pasteur, Université Paris Est Créteil (UPEC) - IMRB, Université Paris Saclay and Independent
Downloads 271 (280,513)

Abstract:

Loading...

RSV, breakthrough infection, monoclonal antibodies, nirsevimab, resistance

3.

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Number of pages: 28 Posted: 12 Nov 2024
Epiconcept, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, National Institute for Public Health and the Environment (RIVM), Semmelweis University, National Institute of Health Doutor Ricardo Jorge, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute - Department for Infectious Disease Epidemiology, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Health Service Executive, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, NIVEL (Netherlands Institute for Health Services Research), Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute, Université Paris Saclay, Health Service Executive, Instituto de Salud Pública y Laboral de Navarra, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 112 (630,858)
Citation 1

Abstract:

Loading...

COVID-19, Vaccine effectiveness, Test-negative design, Self-test, Bias, Directed acyclic graph, Simulation

4.

Development and Evaluation of Elisa Serological Immunoassays for Influenza and Respiratory Syncytial Viruses

Number of pages: 25 Posted: 24 Feb 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, Hôpital Bicêtre, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Paris-Saclay - UVSQ, VIM, University of Paris-Saclay - UVSQ, VIM, Université Paris Saclay, affiliation not provided to SSRN, Hôpital Paul-Brousse - Service de Virologie and Université Paris Sud - Hôpital Paul Brousse
Downloads 59 (970,490)

Abstract:

Loading...

RSV, influenza, serology, IgG, methods, ELISA